Assessing the Magnitude of Anisometropia in Patients Wearing Misight 1 Day Contact Lens

N/AEnrolling By InvitationNCT06744478

Buddhist Tzu Chi General Hospital50 enrolled

Overview

The effectiveness of Misight 1 Day Contact Lens in retarding anisometropic progression has not been investigated before. This study is aimed to elucidate the efficacy of Misight 1 Day Contact Lens for anisometropia control.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Myopia Anisometropia

Interventions

Misight 1 Day Contact LensDEVICE

Misight 1 Day Contact Lens wearing for myopia control

Eligibility

Sex: ALLMin age: 8 YearsMax age: 23 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 8-23 years old children diagnosed with anisometropia and are willing to accept MiSight® 1 Day contact lens wearing treatment. * No congenital eye diseases or eye diseases such as strabismus and amblyopia. * Those who have been stated to be willing to participate in the program for at least 24 months and accept various evaluations. Exclusion Criteria: * Ocular surface disease( dry eye, keratoconus..) * Allergy to contact lens * Received eye surgery before * The cornea is infected (bacterial, fungal or viral infection). * Strabismus * Premature birth

Locations (1)

Shang-Yen WU

Hualien City, Taiwan

Outcomes

Primary Outcomes

Changes of the visual acuity in myopic children with different Misight 1 Day Contact Lens

The investigators measure the visual acuity of myopic children with different Misight 1 Day Contact Lens.

Time frame: From the date of starting treatment, the visual acuity was measured 1 week, 1month and every 3 months up to 24 months.

Secondary Outcomes

Changes of axial length in myopic children with different Misight 1 Day Contact Lens

The investigators measure the axial length(mm) of eyeball of myopic children with different diopter of Misight 1 Day Contact Lens.

Time frame: From the date of starting treatment, the axial length was measured, then repeat measure were performed every 6 months up to 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.